Skip to content

Efficacy analysis of rapid resection methods for small submucosal gastric tumors

Efficacy analysis of rapid resection methods for small submucosal gastric tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121409
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental Group:Blunt Snare Resection, BSR.Mucosal resection using a snare to expose the tumor, followed by blunt dissection with the snare tip, tumor enucleation and resection with snare ligation,
Control Group:Control Group: Endoscopic Submucosal Dissection (ESD)Standard ESD procedure: submucosal injection to lift the lesion, circumferential marking, mucosal incision, submucosal dissection, wo

Sponsors

The Second Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years; 2. Gastroscopy shows submucosal gastric lesions, and endoscopic ultrasound (EUS) confirms the lesions originate from the muscularis propria, with a maximum diameter <= 1.0 cm; 3. Preoperative imaging (EUS/CT) shows no clear signs of lymph node or distant metastasis; 4. American Society of Anesthesiologists (ASA) classification I-III, able to tolerate sedation or general anesthesia; 5. The patient understands and voluntarily signs a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Significant coagulation dysfunction (INR > 1.5, or platelet count < 80×10^9/L); 2. High-risk features indicated by endoscopy of the lesion (such as surface ulceration, irregular margins); 3. Pregnant or breastfeeding women; 4. History of gastric surgery (which may affect the surgical area); 5. Concurrent severe systemic diseases with an expected survival of less than 1 year; 6. Inability to comply with study follow-up.

Design outcomes

Primary

MeasureTime frame
Operation time (minutes);Direct material cost (CNY);Adverse event rate (bleeding, perforation, infection);Local recurrence rate of tumors;

Secondary

MeasureTime frame
The rate of complete resection;R0 resection rate;

Countries

China

Contacts

Public ContactXiaodong Chen

The Second Affiliated Hospital of Shantou University Medical College

xiaodongchen0712@163.com+86 135 9285 5016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026